User profiles for Jianlin Xu

Jianlin (Jim) Xu

Sanofi
Verified email at sanofi.com
Cited by 1642

[HTML][HTML] Development of an intensified fed-batch production platform with doubled titers using N-1 perfusion seed for cell culture manufacturing

J Xu, MS Rehmann, M Xu, S Zheng, C Hill, Q He… - Bioresources and …, 2020 - Springer
The goal of cell culture process intensification is to increase volumetric productivity, generally
by increasing viable cell density (VCD), cell specific productivity or production bioreactor …

Microbial degradation of perchlorate: principles and applications

J Xu, Y Song, B Min, L Steinberg… - Environmental …, 2003 - liebertpub.com
Perchlorate (ClO 4 - ) release into the environment has occurred primarily in association
with its manufacture and use in solid rocket propellant. When released into groundwater, …

Design and construction of 1D/2D/3D fabric-based wearable micro-supercapacitors

…, X Li, N Yang, X Li, J Yao, W Zhang, R Yan, J Xu… - Journal of Power …, 2023 - Elsevier
Fabric-based micro-supercapacitors have a great potential in the field of wearable flexible
energy storage devices because of the controllable volume, changeable structure, intrinsic …

New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer

H Qiang, Q Chang, J Xu, J Qian, Y Zhang, Y Lei… - Journal of Cancer …, 2020 - Springer
Purpose Tumor growth relies on the sufficient blood supply and continuously requires new
blood vessels to maintain, which lead to vascular abnormalities (Folkman, N Engl J Med 285:…

Improving titer while maintaining quality of final formulated drug substance via optimization of CHO cell culture conditions in low-iron chemically defined media

J Xu, MS Rehmann, X Xu, C Huang, J Tian, NX Qian… - MAbs, 2018 - Taylor & Francis
During biopharmaceutical process development, it is important to improve titer to reduce
drug manufacturing costs and to deliver comparable quality attributes of therapeutic proteins, …

Online/at‐line measurement, analysis and control of product titer and critical product quality attributes (CQAs) during process development

…, V Ehamparanathan, Y Song, J Xu… - Biotechnology and …, 2020 - Wiley Online Library
Process analytical technology (PAT) has been defined by the Food and Drug Administration
as a system for designing, analyzing, and controlling manufacturing through timely …

Combination of chemotherapy and gefitinib as first‐line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: a randomized …

B Han, B Jin, T Chu, Y Niu, Y Dong, J Xu… - … journal of cancer, 2017 - Wiley Online Library
To explore the optimal treatment strategy for patients who harbor sensitive EGFR mutations,
a head‐to‐head study was performed to compare chemotherapy and gefitinib in …

Biomanufacturing evolution from conventional to intensified processes for productivity improvement: a case study

J Xu, X Xu, C Huang, J Angelo, CL Oliveira, M Xu, X Xu… - MAbs, 2020 - Taylor & Francis
Process intensification has shown great potential to increase productivity and reduce costs in
biomanufacturing. This case study describes the evolution of a manufacturing process from …

EGFR tyrosine kinase inhibitor (TKI) in patients with advanced non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: A real-world study in China

J Xu, B Jin, T Chu, X Dong, H Yang, Y Zhang, D Wu… - Lung cancer, 2016 - Elsevier
Introduction There are a number of uncommon EGFR mutations whose associations with
TKIs are not well clarified. Here, we summarize the clinical data of patients with multiple …

Brown drug substance color investigation in cell culture manufacturing using chemically defined media: A case study

J Xu, M Jin, H Song, C Huang, X Xu, J Tian, NX Qian… - Process …, 2014 - Elsevier
Drug substance (DS) color is an important quality attribute for release, stability and comparability
studies of biologics. With the increase of DS concentrations and biologics pipelines …